JOINT FILING AGREEMENTJoint Filing Agreement • February 21st, 2014 • LCC Legacy Holdings Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 21st, 2014 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001, of Argos Therapeutics Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.